최신 재무제표(Form-10K)에 따르면, Mushrooms Inc의 총 자산은 $0이며, 순손실입니다.
MSRM의 주요 재무 비율은 무엇인가요?
Mushrooms Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Mushrooms Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Mushrooms Inc 주요 수익원은 Mycelium for the Creation of Carbon Neutral Products이며, 최신 수익 발표에서 수익은 2,384입니다. 지역별로는 United States이 Mushrooms Inc의 주요 시장이며, 수익은 2,384입니다.
Mushrooms Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Mushrooms Inc의 순손실은 $0입니다.
Mushrooms Inc에 부채가 있나요?
no, Mushrooms Inc의 부채는 0입니다.
Mushrooms Inc의 발행 주식은 몇 주인가요?
Mushrooms Inc의 총 발행 주식은 0주입니다.
주요 통계
이전 종가
$0.0162
시가
$0.018
일일 범위
$0.017 - $0.018
52주 범위
$0.01 - $0.039
거래량
5.0K
평균 거래량
68.6K
배당수익률
--
EPS(TTM)
--
시가총액
$808.9K
MSRM란 무엇인가요?
Mushrooms, Inc. is a development stage company, which acquires and builds a portfolio of cannabis markets. The company is headquartered in Estero, Florida. The company went IPO on 2006-11-17. The company is engaged in the biotechnology and sustainable healthcare solutions using mushrooms and mycelium. The firm is focused on the industrial application of mycelium for the creation of carbon-neutral products for the building and health care industries, as well as creating supplements based on the proven health benefits of mushrooms. Mycelium is a natural fiber that can be used as an alternative to plastics. Mycelium can be used in applications such as insulation, structural insulating panels, acoustical tiles, and building blocks. The company is improving the threads and fabrics in use with its antimicrobial, anti-MRSA, renewable and eco-positive threads and fabric solutions. The company also works together with scientists and medical supply innovators to implement this technology into the range of potential medical applications.